447 related articles for article (PubMed ID: 29930472)
1. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.
Wang Y; Chen JJ; Wang XF; Wang Q
World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472
[TBL] [Abstract][Full Text] [Related]
2. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor.
Qu WZ; Wang L; Chen JJ; Wang Y
World J Gastroenterol; 2023 Jul; 29(26):4200-4213. PubMed ID: 37475847
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors.
Cai HX; Li XQ; Wang SF
World J Gastroenterol; 2018 Nov; 24(44):5046-5056. PubMed ID: 30510379
[TBL] [Abstract][Full Text] [Related]
4. Loss of RKIP expression is associated with poor survival in GISTs.
Martinho O; Gouveia A; Silva P; Pimenta A; Reis RM; Lopes JM
Virchows Arch; 2009 Sep; 455(3):277-84. PubMed ID: 19705153
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors.
Liu LC; Xu WT; Wu X; Zhao P; Lv YL; Chen L
World J Gastroenterol; 2013 Apr; 19(16):2473-80. PubMed ID: 23674848
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
[TBL] [Abstract][Full Text] [Related]
7. Expression of Fatty Acid-Binding Protein-3 in Gastrointestinal Stromal Tumors and Its Significance for Prognosis.
Chen X; Hu SL; Feng Y; Li P; Mao QS; Xue WJ
J Surg Res; 2021 Apr; 260():462-466. PubMed ID: 33272594
[TBL] [Abstract][Full Text] [Related]
8. Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes.
Yang F; Jin C; Du Z; Subedi S; Jiang Y; Li J; Di Y; Zhou Z; Tang F; Fu D
Am J Surg; 2013 Sep; 206(3):360-7. PubMed ID: 23673012
[TBL] [Abstract][Full Text] [Related]
9. Comparative clinical features and short-term outcomes of gastric and small intestinal gastrointestinal stromal tumours: a retrospective study.
Yang Z; Wang F; Liu S; Guan W
Sci Rep; 2019 Jul; 9(1):10033. PubMed ID: 31296939
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumors of the rectum: Clinical, pathologic, immunohistochemical characteristics and prognostic analysis.
Dong C; Jun-Hui C; Xiao-Jun Y; Mei K; Bo W; Chen-Fe J; Wei-Li Y
Scand J Gastroenterol; 2007 Oct; 42(10):1221-9. PubMed ID: 17852882
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of raf kinase inhibitor protein in esophageal squamous cell carcinoma.
Gao C; Pang L; Ren C; Ma T
Pathol Oncol Res; 2012 Apr; 18(2):471-7. PubMed ID: 22102006
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic significance of CC chemokine receptor type 8 protein expression in gastrointestinal stromal tumors.
Li HL; Wang LH; Hu YL; Feng Y; Li XH; Liu YF; Li P; Mao QS; Xue WJ
World J Gastroenterol; 2020 Aug; 26(31):4656-4668. PubMed ID: 32884223
[TBL] [Abstract][Full Text] [Related]
13. Clinico-pathological characteristics and prognostic factors of gastrointestinal stromal tumors among a Chinese population.
Li J; Zhang H; Chen Z; Su K
Int J Clin Exp Pathol; 2015; 8(12):15969-76. PubMed ID: 26884871
[TBL] [Abstract][Full Text] [Related]
14. Dynamic survival analysis of gastrointestinal stromal tumors (GISTs): a 10-year follow-up based on conditional survival.
Xu SJ; Zhang SY; Dong LY; Lin GS; Zhou YJ
BMC Cancer; 2021 Nov; 21(1):1170. PubMed ID: 34724907
[TBL] [Abstract][Full Text] [Related]
15. Reduced Raf-1 kinase inhibitor protein expression predicts less favorable outcomes in patients with hepatic colorectal metastasis.
Kim HS; Park SJ; Lee KY; Park YK; Kim YW
Oncol Rep; 2012 Jul; 28(1):161-71. PubMed ID: 22562283
[TBL] [Abstract][Full Text] [Related]
16. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
[TBL] [Abstract][Full Text] [Related]
17. Tumor sites and microscopic indicators are independent prognosis predictors of gastrointestinal stromal tumors.
Qi Y; Zhao W; Wang Z; Li T; Meng X
Tohoku J Exp Med; 2014 May; 233(1):65-72. PubMed ID: 24827382
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of gastric gastrointestinal stromal tumors in Shandong Province: a midterm report of multicenter GISSG1201 study].
Hou Q; Luo W; Li L; Dai Y; Jiang L; Wang A; Chu X; Li Y; Yang D; Lu C; Yao L; Cui G; Lin H; Chen G; Cui Q; Zhang H; Lun Z; Xia L; Su Y; Han G; Hui X; Wei Z; Sun Z; Guo H; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1025-1030. PubMed ID: 28900994
[TBL] [Abstract][Full Text] [Related]
20. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients.
Al-Mulla F; Hagan S; Behbehani AI; Bitar MS; George SS; Going JJ; García JJ; Scott L; Fyfe N; Murray GI; Kolch W
J Clin Oncol; 2006 Dec; 24(36):5672-9. PubMed ID: 17179102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]